Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics

This page shows the latest Crescendo Biologics news and features for those working in and with pharma, biotech and healthcare.

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

float. Read more here on Charles Li’s blogCrescendo Biologics raises $70m with new investors. ... Read the Crescendo Biologics release here.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Crescendo Biologics appoints Edward Stewart as chief business officer Crescendo Biologics appoints Edward Stewart as chief business officer

    Crescendo Biologics appoints Edward Stewart as chief business officer. He joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals. ... Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer.

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    Cambridge, UK-based Crescendo Biologics has appointed Theodora Harold as its new chief financial officer. ... Dr Peter Pack, chief executive officer of Crescendo Biologics, said: “ Theo's appointment as Crescendo's new chief financial officer places us

  • C4X Discovery appoints chief executive officer C4X Discovery appoints chief executive officer

    Since joining GlaxoSmithKline's research department in 1988, Dix has held a series of senior leadership positions including chief executive officer of Convergence Pharmaceuticals and chairman of both Crescendo Biologics and

  • Crescendo Biologics appoints Dr Kevin Johnson as chairman Crescendo Biologics appoints Dr Kevin Johnson as chairman

    Crescendo Biologics appoints Dr Kevin Johnson as chairman. Brings Cambridge, UKfirm experience from Pangenetics. ... He said: “ Crescendo Biologics has a very promising pipeline in development based on its unique Humabodies platform. “

  • Crescendo Biologics appoints Peter Pack as CEO Crescendo Biologics appoints Peter Pack as CEO

    Crescendo Biologics appoints Peter Pack as CEO. Launches new strategy in oncology R&D. ... Crescendo Biologics has appointed Dr Peter Pack as CEO who will help to oversee the company's new strategy.

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics